Condition: Immune Thrombocytopenia · Thrombotic Thrombocytopenic Purpura · Hemophilia A, Acquired · Sponsor: Peking University People's Hospital
This is a multicenter, prospective, longitudinal, observational cohort study to investigate thrombosis and hemostasis diseases in Chinese patients. This study will collect basic information, diagnostic and treatment information, as well as medical expense information of patients from medical records.The incidence and risk factors of thrombosis and hemostasis diseases, the treatment methods, prognosis and medical expenses of these patients in China will be analyzed. The study will use questionnaire to measure the exposure of patients, and prospectively follow-up to collect the prognosis information.
This description comes directly from the study's public registry record.
Haixia Fu, MD · 086-01088326002 · fuhaixia_210@163.com
Zhuoyu An · 086-01088326001
Always discuss trial participation with your own doctor first.
| Peking University Insititute of Hematology, Peking University People's Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Department of Hematology, Beijing Friendship Hospital, Capital Medical University | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Department of Hematology, Beijing Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou, Henan, China | Not Yet Recruiting |
| Xinqiao Hospital, Army Military Medical University | Chongqing, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06727669